众安在线 分时图 日K线 周K线 月K线 15.39 0.42 2.81% 3.01% 2.00% 1.00% 0.00% 1.00% 2.00% 3.01% 14.52 14.67 14.82 14.97 15.12 15.27 15.42 09:30 10:30 12:00/13:00 14:00 16:10 0 155万 310万 466万 众安在线(06060)发布公告，本公司于2025年1月1日至2025年11月30日所获得的原保险保费收入总额约 为人民币329.04亿元。 ...

Company News - China COSCO Shipping Energy Transportation Co., Ltd. (中远海能) has signed shipbuilding contracts with Dalian COSCO Shipping Heavy Industry, Yangzhou COSCO Shipping Heavy Industry, and Guangdong COSCO Shipping Heavy Industry for the construction of one ethylene ship and eighteen oil tankers, with a total cost of RMB 7.882 billion [1] - ZhongAn Online P&C Insurance Co., Ltd. (众安在线) reported a total original insurance premium income of approximately RMB 32.904 billion for the first eleven months [2] - R&F Properties Co., Ltd. (富力地产) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, representing a year-on-year increase of 24.63% [3] - Yida China Holdings Limited (亿达中国) reported a contracted sales amount of approximately RMB 681 million for the first eleven months, a year-on-year decrease of 23.22% [4] - Karsen International Holdings Limited (卡森国际) has entered into a steel structure procurement contract with suppliers, involving an investment of RMB 43.5366 million [4] Clinical and Regulatory Updates - Bolex Cloud-B (拨康视云-B) successfully held a meeting after the second phase of clinical trials for CBT-004 [5] - Innovent Biologics, Inc. (复宏汉霖) has had its application for the marketing registration of Hansizhuang® combined chemotherapy for gastric cancer accepted by the National Medical Products Administration, and it has been included in the priority review [5] - CSPC Pharmaceutical Group Limited (石药集团) received approval for a new indication for Donyi® (Irinotecan Liposome Injection) for first-line treatment in patients with metastatic pancreatic cancer [5] - Heng Rui Medicine (恒瑞医药) received a clinical trial approval notice for HRS-1780 tablets [7] Investment and Acquisition Activities - AVIC Aviation Industry Corporation (中航科工) plans to acquire a 59.1816% partnership interest in Hangtou Yuhua for a consideration of RMB 202 million [8] - China Environment Resources Holdings Limited (中国环境资源) intends to acquire 90% equity in Sichuan Yuanlai Shun Recycling Resources Co., Ltd. for RMB 9 million [9] - AVIC Aviation Industry Corporation (中航科工) has proposed to implement full circulation of H-shares [10] - Yabo Technology Holdings Limited (亚博科技控股) has entered into a framework agreement with Alipay (Hangzhou) [11] Financing and Buyback Activities - Yum China Holdings, Inc. (百胜中国) has entered into a share buyback agreement with a total repurchase amount of approximately USD 460 million, including about HKD 880 million under the Hong Kong plan, as part of a plan to return USD 1.5 billion to shareholders through dividends and share buybacks by 2026 [12] - Tencent Holdings Limited (腾讯控股) repurchased approximately 1.044 million shares for about HKD 636 million, with repurchase prices ranging from HKD 601.5 to HKD 616 [13] - Xuanwu Cloud (玄武云) repurchased 6,000 shares for a total of HKD 6,467.79, with prices between HKD 1.05 and HKD 1.07 [14] - China COSCO Shipping Holdings Co., Ltd. (中远海控) repurchased approximately 4.461 million shares for about HKD 60.8605 million, with prices ranging from HKD 13.38 to HKD 13.82 [15] - Geely Automobile Holdings Limited (吉利汽车) repurchased approximately 1.362 million shares for about HKD 23.9241 million, with prices between HKD 17.29 and HKD 17.82 [16] - China Anshun Energy (中国安储能源) plans to issue a total of 524 million shares at a discount of approximately 19.12%, aiming to raise about HKD 288.2 million [16]

12月12日金融一线消息，众安在线今日发布保费收入公告。数据显示，公司于2025年1月1日至2025年11 月30日所获得的原保险保费收入总额约为人民币329.04亿元。 (股份代號：6060) 關 於 保 費 收 入 的 公 告 眾安在綫財產保險股份有限公司([本公司])於2025年1月1日至2025年11月30日 所獲得的原保險保要收入總額約為人民幣32,904百萬元。上述資料按照中華人民共 和國財政部《企業會計準則第25號一原保險合同》(財會 |2006]3號)及《保險合同相關 會計處理規定》(財會[2009]15號)編製,未經審核及未經本公司審計與消費者權益 保護委員會審閱。本公司股東及潛在投資者務須審慎,以免不恰當依賴該等資料。 责任编辑：曹睿潼 12月12日金融一线消息，众安在线今日发布保费收入公告。数据显示，公司于2025年1月1日至2025年11 月30日所获得的原保险保费收入总额约为人民币329.04亿元。 香港交易及结算所有限公司及香港聯合交易所有限公司對本公告的内容櫃不負責,對其地聯性或宗 整性亦不發表任何聲明,並明確表示,擁不對因本公告全部或任何部分内容而產生或因倚媚談等內 容而引致的 ...

格隆汇12月12日丨 众安在线(06060.HK)公告，于2025年1月1日至2025年11月30日所获得的原保险保费 收入总额约为人民币329.04亿元。 ...

智通财经APP讯，众安在线(06060)发布公告，本公司于2025年1月1日至2025年11月30日所获得的原保险 保费收入总额约为人民币329.04亿元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 眾安在綫財產保險股份有限公司 ZHONGAN ONLINE P & C INSURANCE CO., LTD.* （於中華人民共和國註冊成立的股份有限公司，並以「ZA Online Fintech P & C」在香港經營業務） （股份代號：6060） 關於保費收入的公告 眾安在綫財產保險股份有限公司（「本公司」）於2025年1月1日至2025年11月30日 所獲得的原保險保費收入總額約為人民幣32,904百萬元。上述資料按照中華人民共 和國財政部《企業會計準則第25號－原保險合同》（財會[2006]3號）及《保險合同相關 會計處理規定》（財會[2009]15號）編製，未經審核及未經本公司審計與消費者權益 保護委員會審閱。本公司股東及潛在投資者務須審慎，以免不恰當依賴該等資料。 承董事會命 眾安在綫財產保險股份有限公司 董事長 尹海 中國上海，2025年12月12日 於本公告日期，本公司董事會包括兩名執行 ...

Market Overview - The market sentiment improved significantly due to favorable news from the Central Economic Work Conference, with the Hang Seng Index rising by 1.75% and returning to 26,000 points [1] - Major technology stocks collectively increased, with NetEase rising over 4%, Tencent and Alibaba up over 2%, and other tech companies like Xiaomi, Baidu, JD.com, and Kuaishou also seeing gains [1][3] Sector Performance - **Electric Power Equipment**: Strong performance with Dongfang Electric up over 13% and other companies like Harbin Electric and Shanghai Electric also showing significant gains [1][5] - **Financial Sector**: All major financial stocks, including China Pacific Insurance and CITIC Securities, saw increases, with HSBC reaching a market value of over HKD 2 trillion [1][8] - **Precious Metals**: Gold and silver prices surged, leading to active trading in gold stocks, with China Silver Group rising nearly 6% [1][6] - **Consumer Sector**: Restaurant stocks were active, with companies like Da Shi and Haidilao seeing notable increases, driven by policies aimed at boosting consumption [10] - **Real Estate**: Property stocks rose, with Longguang Group increasing over 4%, supported by policies to stabilize the real estate market [12] Individual Stock Highlights - **NetEase**: Stock price increased by 4.20% to HKD 218.40 [4] - **Dongfang Electric**: Stock price surged by 13.59% to HKD 24.90 [5] - **China Pacific Insurance**: Stock price rose by 5.68% to HKD 34.60 [9] - **China Silver Group**: Stock price increased by 5.80% to HKD 0.730 [7] - **Xuan Bamboo Bio**: Stock price increased by 25.19% to HKD 96.90, reaching a new high [16][19] Economic Policy Impact - The Central Economic Work Conference emphasized the importance of domestic demand and consumer spending, with plans to implement measures to boost consumption and stabilize the real estate market [10][12]

IT之家 12 月 10 日消息，乐奇 Rokid 今日官宣推出行业首个专为 AI 眼镜打造的碎屏保障服务 RokidCare。 RokidCare 由乐奇 Rokid 与蚂蚁保、众安保险联合推出，遇到意外导致的主屏幕碎裂，RokidCare 即会启动。 IT之家获悉，RokidCare 服务的价格为 199 元 / 年、299 元 / 两年，覆盖意外碎屏、进水、自然开裂，可一次置换原厂新件。用户线上 30 秒报案，快递上 门取件，备件 24 小时内发货。 用户可通过熟悉的支付宝蚂蚁保平台一键投保，一旦出险，维修或更换服务将由乐奇 Rokid 官方售后体系承接。 IT之家 12 月 10 日消息，乐奇 Rokid 今日官宣推出行业首个专为 AI 眼镜打造的碎屏保障服务 RokidCare。 RokidCare 由乐奇 Rokid 与蚂蚁保、众安保险联合推出，遇到意外导致的主屏幕碎裂，RokidCare 即会启动。 IT之家获悉，RokidCare 服务的价格为 199 元 / 年、299 元 / 两年，覆盖意外碎屏、进水、自然开裂，可一次置换原厂新件。用户线上 30 秒报案，快递上 门取件，备件 24 小时内 ...

Investment Rating - The report maintains an "Outperform the Market" investment rating for the insurance industry [1][4]. Core Insights - The release of the Commercial Health Insurance Innovative Drug Directory marks a significant step for commercial health insurance in the innovative drug payment sector, creating a "second battlefield" that complements the basic medical insurance directory [2][13]. - The new policy alleviates the long-standing conflict between cost control pressures in medical insurance and the innovation demands of pharmaceutical companies, injecting momentum into the healthy development of China's innovative drug industry [2][13]. - The unified directory standardizes fragmented special drug demand and centralizes payment data, providing a reusable "public infrastructure" for the industry, enabling insurance companies to sustainably manage risks in the innovative drug sector for the first time [2][13]. Summary by Sections Policy Positioning - The introduction of the innovative drug directory clarifies the boundaries between basic medical insurance and commercial health insurance in the innovative drug payment field, allowing commercial insurance to play a supplementary role in the multi-tiered medical security system [3][10]. Market Size and Growth - In 2024, the commercial health insurance premium income reached 977.3 billion yuan, nearing the scale of resident medical insurance funding for the same year. However, the total payment for innovative drugs by commercial health insurance was only 7.4 billion yuan, representing a mere 5.3% of the 140 billion yuan innovative drug market [3][6]. Payment Mechanism - The directory employs a price negotiation mechanism, granting companies greater pricing power, which is beneficial for rapid cost recovery of R&D and encourages innovation in the pharmaceutical sector [6][8]. Liability Side - The implementation of the commercial health insurance directory is expected to clarify the boundaries of medical insurance and commercial insurance, thereby increasing demand for medical insurance products [10]. Asset Side - The directory provides insurance funds with opportunities for deep integration with the medical industry, allowing for a dual approach of "insurance + investment" to achieve excess returns [12][13]. Investment Recommendations - The report suggests focusing on companies with differentiated advantages in the health insurance sector, such as China Property & Casualty Insurance, Ping An Insurance, China Taiping Insurance, and ZhongAn Online [2][13].

眾安在綫財產保險股份有限公司 ZHONGAN ONLINE P & C INSURANCE CO., LTD.* （股份代號：6060） （「發行人」） （於中華人民共和國註冊成立的股份有限公司，並以「ZA Online Fintech P & C」在香港經營業務） (I) 300,000,000美元於2026年到期的3.50%票據（「首批票據」）； 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購證券之邀請或要約。 本公告並不構成或組成在美國境內購買或認購證券的任何要約或招攬的一部分。證券並未及將不會 根據1933年美國證券法（經修訂）（「證券法」）或向美國任何州或其他司法權區的任何證券監管機構登 記。證券乃根據證券法S規例在美國境外提呈發售及出售，且不得在未有根據證券法登記或獲證券 法豁免登記的情況下在美國境內提呈發售或出售。將不會在美國境內或有關發售受限制或禁止的任 何其他司法權區公開發售證券。 （「第二 ...